
New alliance with Gilead Sciences is ‘transformative’
Research collaboration pairs Yale experts with industry scientists to accelerate the development of new drugs to treat cancer
When Robert J. Alpern, M.D., dean of the School of Medicine, was asked recently to prepare a brief overview of the current state of drug discovery for a symposium at Yale’s West Campus, a familiar phrase came quickly to mind: “It was the best of times, it was the worst of times . . . ”It’s an apt description. On the one hand, we live in what some call the “post-Gleevec era,” a time when basic research conducted over decades is bearing fruit in the form of remarkably effective, targeted drugs....
Donation from leading Asian foundation will advance stem cell science

The Li Ka Shing Foundation (LKSF), Asia’s largest philanthropic organization, has made a $1.5 million donation to the Yale Stem Cell Center (YSCC). The donation will fund improvements in two of the YSCC’s four core laboratories that will benefit the work of more than 60 faculty members and numerous trainees across the campus.In announcing the contribution, Yale University President Richard C. Levin said, “We are grateful for the Li Ka Shing Foundation’s generosity, which benefits today’s medical research in order to develop...

Symposium is ‘once-in-a-lifetime event’
A roster of top biomedical scientists visits Yale for two days of talks and intellectual exchange, along with a generous helping of good cheer
A new alternative for asthma patients
Asthma can be difficult to treat, so physicians at the Yale Center for Asthma and Airway Disease (YCAAD) are always...
A famously funny man backs Yale work on a deadly serious disease
For author, blogger, raconteur, and talk-show host Dick Cavett, when the topic is depression, it’s personal. Cavett had...
Charitable gift annuities: a good choice for today's economy
Frustrated by low returns on your investments? Worried about volatility in the stock market? A charitable gift annuity...

Tackling an information explosion
Chair worries that the U.S. is not ready for the coming deluge of medical data











